In the B56αhm/hm mice, DMBA/TPA treatment also induced earlier development of papillomas, but in contrast to the K14.Myc2 mice, no difference in total endpoint number of lesions or progression of lesions was observed. This evidence concerns the gene KRT14 and papilloma.